Sponsored Webcast: Breaking Through The Nams Noise: Impact Of FDA's Roadmap On Nams For Drug Safety Testing
Virtual Programs 
Biologics/ biosimilars/ vaccinesCombination products/companion diagnosticsIntermediatePharmaceuticalsPreclinical studyRegulatory Intelligence/PolicyResearch, Design and DevelopmentUnited States